Newsworthy

Crohn’s Disease Clinical Trial Recruitment

The AFFIRM Study is looking for adults who are 18 years of age or older, with moderate to severe Crohn’s disease (CD). The study is researching a study drug to see if it can safely be given subcutaneously (an injection under the skin) with the goal of inducing “remission” in adults with CD. Remission is the point where CD symptoms start to go away or disappear completely. To see whether you might be eligible, please visit our website www.AFFIRMstudyCD.com, or contact the Cotton O’Neil Digestive Health Clinical Research Center to learn more: (785) 270-4856.

Posted in

In Other News

Dr. Yaman Alali Joins the Stormont Vail Health Cancer Care Team

Yaman_Alali_tb

Stormont Vail Health Earns PTAP Accreditation for Nurse Residency Program       

IMG_8271

Better Outcomes Start with a Picture

2025.10.18 - WWAD-SVNet - Hashmi

National APP Week 2025: Sept. 22–26

AppWeek-Graphics-StormConn

Stormont Vail Community News Sept. 23, 2025

svh_generic_tb_2025